Skip to main content
. 2024 Sep 26;2024(9):CD006689. doi: 10.1002/14651858.CD006689.pub3

6.5. Analysis.

6.5

Comparison 6: Mefloquine (MQ) versus sulfadoxine‐pyrimethamine (SP), Outcome 5: Adverse events: nausea